Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne L Taylor

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
American Heart Journal|July 12, 2011
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT)Judith E Mitchell, S William Tam, Kamini Trivedi, et al.
American Heart Journal|October 18, 2003
Screening for early detection of cardiovascular disease in asymptomatic individualsJay N Cohn, Lynn Hoke, Wayne Whitwam, et al.
Journal of Cardiac Failure|November 11, 2008
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure TrialJalal K Ghali, S William Tam, Michael L Sabolinski, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2010
New recommendations for treating hypertension in black patients: evidence and/or consensus?Jackson T Wright, Lawrence Y Agodoa, Lawrence Appel, et al.
Journal of Women'S Health (2002)|February 18, 2010
The Office on Women's Health initiative to improve women's heart health: program description, site characteristics, and lessons learnedJoAnne M Foody, Amparo C Villablanca, Elsa-Grace V Giardina, et al.
Journal of Cardiac Failure|August 4, 2012
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trialAnne L Taylor, Michael L Sabolinski, S William Tam, et al.
JACC. Heart Failure|October 13, 2014
G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFTDennis M McNamara, Anne L Taylor, S William Tam, et al.
Journal of Women'S Health (2002)|April 16, 2011
The DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factorsElsa-Grace V Giardina, Robert R Sciacca, JoAnne M Foody, et al.
Journal of Cardiac Failure|July 26, 2002
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodologyJoseph A Franciosa, Anne L Taylor, Jay N Cohn, et al.
The New England Journal of Medicine|November 10, 2004
Combination of isosorbide dinitrate and hydralazine in blacks with heart failureAnne L Taylor, Susan Ziesche, Clyde Yancy, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
American Heart Journal|July 12, 2011
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT)Judith E Mitchell, S William Tam, Kamini Trivedi, et al.
American Heart Journal|October 18, 2003
Screening for early detection of cardiovascular disease in asymptomatic individualsJay N Cohn, Lynn Hoke, Wayne Whitwam, et al.
Journal of Cardiac Failure|November 11, 2008
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure TrialJalal K Ghali, S William Tam, Michael L Sabolinski, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2010
New recommendations for treating hypertension in black patients: evidence and/or consensus?Jackson T Wright, Lawrence Y Agodoa, Lawrence Appel, et al.
Journal of Women'S Health (2002)|February 18, 2010
The Office on Women's Health initiative to improve women's heart health: program description, site characteristics, and lessons learnedJoAnne M Foody, Amparo C Villablanca, Elsa-Grace V Giardina, et al.
Journal of Cardiac Failure|August 4, 2012
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trialAnne L Taylor, Michael L Sabolinski, S William Tam, et al.
JACC. Heart Failure|October 13, 2014
G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFTDennis M McNamara, Anne L Taylor, S William Tam, et al.
Journal of Women'S Health (2002)|April 16, 2011
The DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factorsElsa-Grace V Giardina, Robert R Sciacca, JoAnne M Foody, et al.
Journal of Cardiac Failure|July 26, 2002
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodologyJoseph A Franciosa, Anne L Taylor, Jay N Cohn, et al.
The New England Journal of Medicine|November 10, 2004
Combination of isosorbide dinitrate and hydralazine in blacks with heart failureAnne L Taylor, Susan Ziesche, Clyde Yancy, et al.
Pageof 6